Filing Details

Accession Number:
0001127602-14-004178
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-04 12:22:59
Reporting Period:
2014-02-03
Filing Date:
2014-02-04
Accepted Time:
2014-02-04 12:22:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
912183 Cubist Pharmaceuticals Inc CBST Pharmaceutical Preparations (2834) 223192085
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1210238 Kenneth Bate 65 Hayden Avenue
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-03 6,250 $22.71 14,164 No 4 M Direct
Common Stock Disposition 2014-02-03 5,250 $72.02 8,914 No 4 S Direct
Common Stock Disposition 2014-02-03 1,000 $72.83 7,914 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2014-02-03 6,250 $0.00 6,250 $22.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2007-06-08 2016-06-08 No 4 M Direct
Footnotes
  1. Sold pursuant to a Rule 10(b)5-1 Plan.
  2. This transaction was executed in multiple trades at prices ranging from $71.7850 to $72.5600. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  3. Option vests 100% on one-year anniversary of grant.